239 related articles for article (PubMed ID: 10358030)
1. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
[TBL] [Abstract][Full Text] [Related]
2. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
Oosterom J; Burbach JP; Gispen WH; Adan RA
Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
[TBL] [Abstract][Full Text] [Related]
3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
4. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
5. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
[TBL] [Abstract][Full Text] [Related]
6. D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity.
Grieco P; Balse PM; Weinberg D; MacNeil T; Hruby VJ
J Med Chem; 2000 Dec; 43(26):4998-5002. PubMed ID: 11150170
[TBL] [Abstract][Full Text] [Related]
7. Identification of domains directing specificity of coupling to G-proteins for the melanocortin MC3 and MC4 receptors.
Kim CS; Lee SH; Kim RY; Kim BJ; Li SZ; Lee IH; Lee EJ; Lim SK; Bae YS; Lee W; Baik JH
J Biol Chem; 2002 Aug; 277(35):31310-7. PubMed ID: 12045190
[TBL] [Abstract][Full Text] [Related]
8. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors.
Lee EJ; Lee SH; Jung JW; Lee W; Kim BJ; Park KW; Lim SK; Yoon CJ; Baik JH
Eur J Biochem; 2001 Feb; 268(3):582-91. PubMed ID: 11168397
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
[TBL] [Abstract][Full Text] [Related]
11. Minimization of MC1R selectivity by modification of the core structure of alpha-MSH-ND.
Lim S; Li S; Lee C; Yoon C; Baik J; Lee W
Chem Biol; 2001 Sep; 8(9):857-70. PubMed ID: 11564554
[TBL] [Abstract][Full Text] [Related]
12. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
13. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
14. Melanocortins and cardiovascular regulation.
Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
[TBL] [Abstract][Full Text] [Related]
15. Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes.
Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
Eur J Pharmacol; 1998 May; 349(2-3):359-66. PubMed ID: 9671118
[TBL] [Abstract][Full Text] [Related]
16. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the melanocortin 4 receptor by radioligand binding.
Schiöth HB; Muceniece R; Wikberg JE
Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity.
Nickolls SA; Cismowski MI; Wang X; Wolff M; Conlon PJ; Maki RA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1217-27. PubMed ID: 12604699
[TBL] [Abstract][Full Text] [Related]
20. Type I beta-turn conformation is important for biological activity of the melanocyte-stimulating hormone analogues.
Li SZ; Lee JH; Lee W; Yoon CJ; Baik JH; Lim SK
Eur J Biochem; 1999 Oct; 265(1):430-40. PubMed ID: 10491201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
